OXT and prostate cancer: While OT is considered a putative tumor suppressor, its ability to act as such raises questions about whether the freeing of OTR from prostate cancer cells that lack caveolae is associated with an increase in growth signaling where OTR is more available to interact with ligands and potentially activate growth signaling pathways.